Nature Publishing Group (NPG) and the Australasian Society for Immunology (ASI) today announce a partnership to publish a new open access journal from December 2012. Clinical and Translational Immunology (CTI) will be a companion title to Immunology and Cell Biology, established in 1924 and currently published by NPG in partnership with the ASI. CTI will be hosted on nature.com and will begin accepting submissions in the second half of 2012.
CTI will publish the latest advances in biomedical research for scientists and physicians. The journal will focus on fields such as cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation. CTI will publish articles on basic, translational, and clinical studies in all aspects of human immunology, including experimental models specific to human diseases. There will also be reviews of timely topics in basic immunology, case reports, and letters to the editor.
The editorial team is led by Editor-in-Chief Gabrielle Belz, of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. An international editorial board supports the editorial team.
Dr Belz said: “The ASI and the editorial team of Immunology and Cell Biology are delighted to be able to form this collaboration with NPG and move forward on this exciting new venture with the sister journal Clinical and Translational Immunology. We are excited to be working with NPG in driving the development of this journal for the community.”
All content will be open access and will be freely available to researchers worldwide through the nature.com platform. An article-processing charge (APC) will be levied per article accepted for publication, and authors will have a choice of two Creative Commons licenses.
“We are pleased to be extending our publishing partnership with the Australasian Society for Immunology,” said Dugald McGlashan, Publisher of NPG’s Asia-Pacific Academic Journals. “Published for more than 80 years, Immunology and Cell Biology is well known for its focus on the cell biology of the immune system. With its clinical and translational scope, CTI will complement this well-established journal perfectly.”
NPG works with more than 30 societies and organizations worldwide to provide publishing services and publishes over 50 journals in its academic and society journals program. Open access options are available on more than 90% (55 of 59) of NPG’s academic and society journal portfolio, including Immunology and Cell Biology.
